Plain-English translation of NCT06936124 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This small pilot study is testing a neurosurgical procedure called deep brain stimulation (DBS) as a potential new treatment for Alzheimer's disease. Researchers will surgically implant a device that sends gentle electrical pulses to a specific brain region involved in memory and thinking. The goal is to see whether this treatment can improve cognitive function and slow memory loss in people with early-stage Alzheimer's disease.
Current Alzheimer's treatments only help with symptoms but cannot stop or reverse the disease. This trial is exploring whether electrical brain stimulation might actually modify the disease itself by enhancing brain activity patterns related to memory and cognition, based on encouraging early research.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo surgery to have the electrical stimulation device implanted in your brain, followed by activation and programming of the device. You will then return for follow-up visits every three months over a 12-month period, where researchers will check that the device is working safely, perform brain imaging and electrical recordings, and test your memory and thinking abilities. A caregiver will need to participate in these visits as well.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Canada